Author:
Miskulin Dana C, ,Zhou Jing,Tangri Navdeep,Bandeen-Roche Karen,Cook Courtney,Ephraim Patti L,Crews Deidra C,Scialla Julia J,Sozio Stephen M,Shafi Tariq,Jaar Bernard G,Boulware L Ebony
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Remuzzi G, Ingelfinger JR: Correction of anemia–payoffs and problems. N Engl J Med. 2006, 355: 2144-2146. 10.1056/NEJMe068233.
2. Unger EF, Thompson AM, Blank MJ, Temple R: Erythropoiesis-stimulating agents–time for a reevaluation. N Engl J Med. 2010, 362: 189-192. 10.1056/NEJMp0912328.
3. US Renal Data System: USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2008, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
4. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, Investigators C: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006, 355 (20): 2085-2098. 10.1056/NEJMoa065485.
5. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998, 339: 584-590. 10.1056/NEJM199808273390903.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献